CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale See remarks sold 12,103 shares at an average $3.02 ($36,541)
- 4 Planned sale Chief Financial Officer sold 19,191 shares at an average $3.07 ($58,849)
- 4 Open-market sale President, R&D sold 31,562 shares at an average $3.02 ($95,381)
- 4 Open-market sale Chief Legal Officer sold 14,587 shares at an average $3.02 ($44,040)
- 4 Open-market sale President and CEO sold 61,422 shares at $2.97 ($182,423)
- 4 Open-market sale President, R&D sold 986 shares at $2.84 ($2,800)
- 4 Open-market sale See remarks sold 247 shares at $2.84 ($701)
- 4 Planned sale Chief Financial Officer sold 4,864 shares at $2.84 ($13,814)
- 4 Open-market sale Chief Legal Officer sold 298 shares at $2.84 ($846)
- 4 Open-market sale President and CEO sold 215,506 shares at an average $3.80 ($818,400)
- 4 Open-market sale See remarks sold 45,464 shares at an average $4.50 ($204,753)
- 4 Planned sale Chief Financial Officer sold 58,936 shares at an average $4.55 ($268,339)
- 4 Open-market sale President, R&D sold 80,450 shares at an average $4.50 ($362,298)
- 4 Open-market sale Chief Legal Officer sold 54,479 shares at an average $4.55 ($247,872)
- 4 Planned sale President and CEO sold 375,000 shares at an average $4.70 ($1,762,500)
Page 4 of 16 · 320 filings